Suchergebnisse - "Silvennoinen, Raija"

PubPharm (57)

1

Large differencies in age-specific survival in multiple myeloma in the nordic countries

enthalten in: Blood cancer journal | 2024

von Hemminki, K. | Zitricky, F. | Försti, A. | +3

2

Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma : A Phase 2 Multicenter Study by the Nordic Myeloma Study Group

enthalten in: Cancers | 2024

von Partanen, A. | Waage, A. | Peceliunas, V. | +26

3

Mobilization Strategies in Myeloma Patients Intended for Autologous Hematopoietic Cell Transplantation

enthalten in: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie | 2023

von Jantunen, E. | Partanen, A. | Turunen, A. | +2

4

Real-world evidence of multiple myeloma treated from 2013 to 2019 in the Hospital District of Helsinki and Uusimaa, Finland

enthalten in: Future oncology (London, England) | 2023

von Vikkula, J. | Uusi-Rauva, K. | Ranki, T. | +7

5

Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy

enthalten in: Cancers | 2023

von Luoma, S. | Sergeev, P. | Javarappa, K. | +9

6

Impact of the number of cryopreserved CD34+ cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation : Experience from the GOA study

enthalten in: Journal of clinical apheresis | 2023

von Partanen, A. | Turunen, A. | Silvennoinen, R. | +12

7

A germline exome analysis reveals harmful POT1 variants in multiple myeloma patients and families

enthalten in: EJHaem | 2022

von Hakkarainen, M. | Koski, J. | Heckman, C. | +5

8

Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia : Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia Group

enthalten in: European journal of haematology | 2022

von Kolonen, A. | Sinisalo, M. | Huhtala, H. | +24

9

Efficacy of conventional‐dose cytarabine, idarubicin and thioguanine versus intermediate‐dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia : Long‐term results of the prospective randomized nationwide AML‐2003 study by the Finnish Leukemia Group

enthalten in: European Journal of Haematology | 2022

von Kolonen, A. | Sinisalo, M. | Huhtala, H. | +23

10

A germline exome analysis reveals harmful POT1 variants in multiple myeloma patients and families

enthalten in: eJHaem | 2022

von Hakkarainen, M. | Koski, J. | Heckman, C. | +5

1
2
3
4
5
6
Nächster »
[6]